ATE528647T1 - Verfahren zur untersuchung von protein-protein- interaktionen - Google Patents

Verfahren zur untersuchung von protein-protein- interaktionen

Info

Publication number
ATE528647T1
ATE528647T1 AT07758759T AT07758759T ATE528647T1 AT E528647 T1 ATE528647 T1 AT E528647T1 AT 07758759 T AT07758759 T AT 07758759T AT 07758759 T AT07758759 T AT 07758759T AT E528647 T1 ATE528647 T1 AT E528647T1
Authority
AT
Austria
Prior art keywords
protein
studying
activator
proteins
interaction
Prior art date
Application number
AT07758759T
Other languages
English (en)
Inventor
Kevin Lee
Brian Pollok
Zhong Zhong
Original Assignee
Life Technologies Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Life Technologies Corp filed Critical Life Technologies Corp
Application granted granted Critical
Publication of ATE528647T1 publication Critical patent/ATE528647T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1055—Protein x Protein interaction, e.g. two hybrid selection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/71—Fusion polypeptide containing domain for protein-protein interaction containing domain for transcriptional activaation, e.g. VP16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/80—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT07758759T 2006-03-16 2007-03-16 Verfahren zur untersuchung von protein-protein- interaktionen ATE528647T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78298006P 2006-03-16 2006-03-16
PCT/US2007/064243 WO2007127538A1 (en) 2006-03-16 2007-03-16 Methods for assaying protein-protein interaction

Publications (1)

Publication Number Publication Date
ATE528647T1 true ATE528647T1 (de) 2011-10-15

Family

ID=38655843

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07758759T ATE528647T1 (de) 2006-03-16 2007-03-16 Verfahren zur untersuchung von protein-protein- interaktionen

Country Status (4)

Country Link
EP (1) EP2002021B1 (de)
JP (1) JP2009529893A (de)
AT (1) ATE528647T1 (de)
WO (1) WO2007127538A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160109438A1 (en) * 2013-06-06 2016-04-21 Agency For Science, Technology And Research Protease-responsive peptide biosensors and methods for analyte detection
WO2015100058A1 (en) * 2013-12-23 2015-07-02 Research Corporation Technologies, Inc. Pichia pastoris surface display system
MX2018008345A (es) 2016-01-11 2018-12-06 Univ Leland Stanford Junior Proteínas quiméricas y métodos de inmunoterapia.
IL260532B2 (en) 2016-01-11 2023-12-01 Univ Leland Stanford Junior Chimeric proteins- containing systems and uses thereof in regulating gene expression
WO2020043812A1 (en) * 2018-08-30 2020-03-05 Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.V. Method for detecting a modulator compound for chemical targeting of protein-protein interactions
AU2019392906A1 (en) * 2018-12-07 2021-07-22 Octant, Inc. Systems for protein-protein interaction screening

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5891646A (en) 1997-06-05 1999-04-06 Duke University Methods of assaying receptor activity and constructs useful in such methods
US6528271B1 (en) 1997-06-05 2003-03-04 Duke University Inhibition of βarrestin mediated effects prolongs and potentiates opioid receptor-mediated analgesia
US7128915B2 (en) 1997-09-18 2006-10-31 Research Development Foundation Membrane virus host range mutations and their uses as vaccine substrates
US6884870B2 (en) 1998-03-20 2005-04-26 California Institute Of Technology Fusion proteins for identifying proteases, protease target sites and regulators of protease activity in living cells
US6893827B1 (en) * 2000-02-07 2005-05-17 Applera Corporation Receptor function assay for G-protein coupled receptors and orphan receptors by reporter enzyme mutant complementation
US20030157553A1 (en) 2000-03-03 2003-08-21 Gabriel Berstein Methods of assaying for G protein-coupled receptor ligands and modulators
EP1205191A1 (de) 2000-11-13 2002-05-15 Centre National De La Recherche Scientifique Zielgerichte Änderung von intrazellular Verbindungen
US6562576B2 (en) * 2001-01-04 2003-05-13 Myriad Genetics, Inc. Yeast two-hybrid system and use thereof
DE10211063A1 (de) * 2002-03-13 2003-10-09 Axaron Bioscience Ag Neue Verfahren zur Detektion und Analyse von Protein-Interaktionen in vivo
EP1353182A3 (de) 2002-04-12 2004-02-04 Smithkline Beecham Corporation Verfahren zur Vorhersage von Zell-basierten Assay Resultaten mit Hilfe von Bindungsprofilen
ATE534900T1 (de) * 2003-07-09 2011-12-15 Life Technologies Corp Verfahren zum testen einer protein-protein- wechselwirkung

Also Published As

Publication number Publication date
WO2007127538A1 (en) 2007-11-08
EP2002021B1 (de) 2011-10-12
EP2002021A1 (de) 2008-12-17
EP2002021A4 (de) 2009-04-22
JP2009529893A (ja) 2009-08-27

Similar Documents

Publication Publication Date Title
ATE534900T1 (de) Verfahren zum testen einer protein-protein- wechselwirkung
Song et al. Development of FRET assay into quantitative and high-throughput screening technology platforms for protein–protein interactions
US9772328B2 (en) Bimolecular protease-based biosensor
ATE528647T1 (de) Verfahren zur untersuchung von protein-protein- interaktionen
Chen et al. Capillary nano-immunoassays: advancing quantitative proteomics analysis, biomarker assessment, and molecular diagnostics
Moser et al. Chromogenic factor VIII activity assay
ATE393228T1 (de) Fusionsproteine und deren verwendung zur messung von protease-aktivität
ATE368127T1 (de) Optische sonden und assays zur messung der proteinphosphorylierung
Steen et al. Substrate specificity of aquatic extracellular peptidases assessed by competitive inhibition assays using synthetic substrates
Lippok et al. Exponential size distribution of von Willebrand factor
DE60317422D1 (de) Mediator-stabilisierende Verbindung und Methoden zur Verwendung zur Detektion elektrochemischer Analyte
ATE553216T1 (de) Sonden, bibliotheken und kits zur analyse von nukleinsäuregemischen und verfahren zu deren konstruktion
JP5461175B2 (ja) 生体媒質中で酵素活性を決定する方法
ATE554106T1 (de) Antikörper für onkogene stämme von hpv und verfahren zu deren verwendung
DE602004026888D1 (de) Kinase- und phosphatasetests
EP2074427A4 (de) Diagnostik-biomolekül(e)
Byzia et al. Activity profiling of aminopeptidases in cell lysates using a fluorogenic substrate library
ATE370414T1 (de) Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs
DE602006006855D1 (de) Morbus alzheimer-spezifische veränderungen des erkheimer-spezifische molekulare biomarker (adsmb)
DE502005005132D1 (de) Verfahren zur erhöhung des dynamischen messbereichs von auf spezifischen bindereaktionen basierenden, insbesondere immunologischen testelementen
ATE468535T1 (de) Verwendung von nnmt als marker für lungenkrebs
ATE525656T1 (de) Proteinmessverfahren
Wagstaff et al. Quantitative analysis of protein–protein interactions by native page/fluorimaging
ATE520028T1 (de) Test zum nachweis von proteinbindung
DE602004001994D1 (de) Verwendung des proteins masp als marker für kolorektale karzinome

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties